SPP1 and metabolic dysfunction-associated steatotic liver disease: In the current study, we used a recently described mouse model, which sequentially develops NASH, fibrosis and HCC on a background of diabetes and obesogenic diet, to finally assess the role of OPN, a putative prognostic and therapeutic target for liver cancer, on the development of HCC in NAFLD.